Verana Health Enhances Clinical Trial Site Selection with Real-World Data Tools
Event summary
- Verana Health launched new dashboards in Site Explorer and Verana Trial Connect to monitor deidentified screening activity in real time.
- The tools leverage real-world data (RWD) from over 95 million de-identified patients across 3,200 practices to streamline site selection and patient enrollment.
- Site Explorer identifies practices with specific patient populations, while Verana Trial Connect automates eligibility reviews using EHR data.
- Verana Health is offering a webinar on May 19, 2026, to discuss proactive planning in clinical trials.
The big picture
Verana Health’s new tools address long-standing inefficiencies in clinical trial enrollment, including redundant site selection and underperforming sites. By leveraging exclusive partnerships with major medical associations, the company aims to reduce delays and improve trial success rates. The move reflects a broader industry shift toward data-driven clinical research, where real-world data is increasingly critical for accelerating therapy development.
What we're watching
- Adoption Pace
- How quickly sponsors and CROs will integrate Verana Health’s tools into their workflows, given the competitive landscape for trial sites.
- Data Accuracy
- Whether the real-world data from Verana Health’s partnerships will consistently improve site selection and reduce trial delays.
- Competitive Response
- How existing clinical trial technology providers will react to Verana Health’s enhanced capabilities in site selection and patient enrollment.
Related topics